Lumateperone bulk supplier for pharma manufacturers

Lumateperone 10.5 mg, 21 mg, 42 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 10.5 mg, 21 mg, 42 mg

Reference Brands: Caplyta (USA)

Lumateperone works by modulating dopamine (D2) and serotonin (5-HT2A) receptors to help balance neurotransmitter activity in the brain. It’s approved for treating schizophrenia and depressive episodes associated with bipolar I or II disorder in adults. It offers effective symptom control with a lower risk of metabolic side effects compared to older antipsychotics.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Lumateperone — third party manufacturing & bulk supply

Lumateperone 10.5 mg, 21 mg, 42 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lumateperone is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lumateperone listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lumateperone →

Back to Listing

Frequently Asked Questions

Lumateperone is listed as Capsules in 10.5 mg, 21 mg, 42 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Lumateperone is referenced against Caplyta (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.